Inovio Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Inovio Pharmaceuticals, Inc.‘s stocks are currently a part of 154 hedge funds’ portfolios, which represents 51.15% of the total amount of its stocks outstanding. This makes up a total of 111.97M shares of Inovio Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 23.59% or 21.37M shares more. As for the holding position changes, 44.16% (68) of current hedge fund investors increased the number of shares held, 22.08% (34) of current holders sold a part of the shares held, and 23.38% (36) closed the holdings completely. 15 hedge funds are new holders of Inovio Pharmaceuticals, Inc. stock in Q2 2022, it is 9.74% of total holders.
Hedge funds holding Inovio Pharmaceuticals (Q3 2017 – Q2 2022)
| Q3 2017 | 121 |
|---|---|
| Q4 2017 | 126 |
| Q1 2018 | 122 |
| Q2 2018 | 119 |
| Q3 2018 | 124 |
| Q4 2018 | 118 |
| Q1 2019 | 119 |
| Q2 2019 | 120 |
| Q3 2019 | 110 |
| Q4 2019 | 100 |
| Q1 2020 | 151 |
| Q2 2020 | 211 |
| Q3 2020 | 206 |
| Q4 2020 | 216 |
| Q1 2021 | 207 |
| Q2 2021 | 200 |
| Q3 2021 | 197 |
| Q4 2021 | 187 |
| Q1 2022 | 175 |
| Q2 2022 | 154 |
Hedge funds changes in Inovio Pharmaceuticals positions (Q3 2017 – Q2 2022)
| Q3 2017 | 20 | 55 | 17 | 13 | 16 |
|---|---|---|---|---|---|
| Q4 2017 | 25 | 35 | 33 | 19 | 14 |
| Q1 2018 | 16 | 38 | 37 | 15 | 16 |
| Q2 2018 | 15 | 35 | 31 | 18 | 20 |
| Q3 2018 | 20 | 47 | 30 | 15 | 12 |
| Q4 2018 | 17 | 40 | 28 | 23 | 10 |
| Q1 2019 | 12 | 49 | 25 | 11 | 22 |
| Q2 2019 | 22 | 36 | 26 | 18 | 18 |
| Q3 2019 | 6 | 37 | 29 | 17 | 21 |
| Q4 2019 | 14 | 36 | 25 | 24 | 1 |
| Q1 2020 | 70 | 40 | 32 | 16 | -7 |
| Q2 2020 | 96 | 72 | 28 | 35 | -20 |
| Q3 2020 | 47 | 86 | 46 | 52 | -25 |
| Q4 2020 | 51 | 72 | 53 | 39 | 1 |
| Q1 2021 | 36 | 86 | 52 | 43 | -10 |
| Q2 2021 | 39 | 69 | 45 | 47 | 0 |
| Q3 2021 | 30 | 58 | 57 | 28 | 24 |
| Q4 2021 | 29 | 66 | 59 | 42 | -9 |
| Q1 2022 | 23 | 51 | 54 | 31 | 16 |
| Q2 2022 | 15 | 68 | 34 | 36 | 1 |
Hedge funds changes in Inovio Pharmaceuticals stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 2,273,000 | 1,198,000 |
|---|---|---|
| Q4 2017 | 405,000 | 504,000 |
| Q1 2018 | 479,000 | 603,000 |
| Q2 2018 | 449,000 | 610,000 |
| Q3 2018 | 1,158,000 | 626,000 |
| Q4 2018 | 705,000 | 298,000 |
| Q1 2019 | 267,000 | 383,000 |
| Q2 2019 | 299,000 | 318,000 |
| Q3 2019 | 71,000 | 124,000 |
| Q4 2019 | 481,000 | 398,000 |
| Q1 2020 | 35,973,000 | 22,246,000 |
| Q2 2020 | 269,206,000 | 229,474,000 |
| Q3 2020 | 116,779,000 | 103,733,000 |
| Q4 2020 | 45,457,000 | 54,014,000 |
| Q1 2021 | 37,833,000 | 43,995,000 |
| Q2 2021 | 34,339,000 | 37,153,000 |
| Q3 2021 | 25,575,000 | 32,461,000 |
| Q4 2021 | 15,541,000 | 18,211,000 |
| Q1 2022 | 3,867,000 | 5,386,000 |
| Q2 2022 | 2,139,000 | 2,821,000 |